Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
27,922,586
-
Shares change
-
-1,509,785
-
Total reported value, excl. options
-
$169,210,192
-
Value change
-
-$14,367,082
-
Number of buys
-
42
-
Number of sells
-
-30
-
Price
-
$6.06
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q2 2016
97 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q2 2016.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,922,586 shares
of 158,835,667 outstanding shares and own 17.6% of the company stock.
Largest 10 shareholders include BRIDGER MANAGEMENT, LLC (5,204,618 shares), FMR LLC (4,859,764 shares), RA CAPITAL MANAGEMENT, LLC (4,531,714 shares), BAKER BROS. ADVISORS LP (2,003,991 shares), UBS ASSET MANAGEMENT AMERICAS INC (1,810,844 shares), VANGUARD GROUP INC (1,484,133 shares), BlackRock Fund Advisors (968,987 shares), BlackRock Institutional Trust Company, N.A. (899,739 shares), STATE STREET CORP (624,307 shares), and COLUMBUS CIRCLE INVESTORS (577,769 shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.